Log in to save to my catalogue

Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on the...

Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on the...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cdb567a4ed65435ca6ad250509502fcf

Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on their efficacy

About this item

Full title

Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on their efficacy

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-10, Vol.12 (1), p.17125-12, Article 17125

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

About 70% of people with osteogenesis imperfecta (OI) experience hearing loss. There is no cure for OI, and therapies to ameliorate hearing loss rely on conventional treatments for auditory impairments in the general population. The success rate of these treatments in the OI population with poor collagenous tissues is still unclear. Here, we conduc...

Alternative Titles

Full title

Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on their efficacy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cdb567a4ed65435ca6ad250509502fcf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cdb567a4ed65435ca6ad250509502fcf

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-20169-9

How to access this item